Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*
PaperCitations, authors & open-access status
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 120 citations, 2020 year and hybrid oa status.
120
Citations
2020
Year
hybrid
OA Status